Compare Keysight Technologies Inc (KEYS) vs Kenvue Inc. Common Stock (KVUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Keysight Technologies Inc vs Kenvue Inc. Common Stock — how do they compare? Keysight Technologies Inc trades at $382.61 (market cap $63.79B), while Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B). The key difference: Keysight Technologies Inc is the larger of the two by market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Keysight Technologies Inc pays none. Which is the better fit depends on your goals.
| KEYS | KVUE | |
|---|---|---|
Market Cap | $63.79B | $34.06B |
Volume | 1,435,384 | 23,267,228 |
Sector | Technology | Consumer Staples |
52-Week High | $387.90 | $19.83 |
52-Week Low | $159.49 | $14.11 |
Typical Hold Time | 56 Days | — |
Enterprise Value | $63.93B | $41.56B |
Dividend Yield | — | 4.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Keysight Technologies (KEYS) trades at $374.66, down 1.79% on the day, with strong technical momentum indicated by bullish moving averages and a consensus price target of $416.63 representing 11.2% upside. The company demonstrates robust fundamentals with Q2 2026 EPS of $3.07 beating expectations by 24%, supported by 56% order growth driven by AI infrastructure demand and 6G development opportunities. Revenue recovery to $5.38B in 2025 and net income margin expansion to 19.14% reflect improving operational efficiency.
KEYS presents compelling growth prospects from AI and 6G tailwinds, though elevated valuation multiples (P/E 50.7) and supply chain constraints pose near-term risks. Wall Street maintains strong bullish sentiment with 81% buy ratings, while technical indicators suggest the stock is testing key resistance at $375 with support at $370. The combination of accelerating earnings, strategic positioning in high-growth markets, and institutional confidence supports a positive medium-term outlook despite valuation concerns.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →
